MarketInOut Stock Screener Log In | Sign Up
 

XBiotech Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
XBiotech Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization60.06 mln
Float23.07 mln
Earnings Date11/12/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

17 / 100
Significantly lagging

ROE

-30.33
Deeply negative

ROA

-29.12
Deeply negative

Business Description

XBiotech is a Texas-based medical research company founded in 2005 that focuses on developing antibody-based treatments for serious health conditions. The company works on therapies targeting inflammation, infection, and diseases such as cancer, arthritis, heart attack, and stroke. Its research also explores how certain proteins in the body contribute to tissue damage, blood clots, and other harmful processes, with the goal of finding new ways to treat these conditions.

Key Fundamentals

EPS-1.48
ROE-30.33
ROIC-199
ROA-29.12
EBITDA, mln-43.42
EV / EBITDA0.98
EV / EBIT0.95

Quote Details

Last 1.93
Change -0.04 (-2.03%)
Open 1.95
Volume 121,734
Turnover 234,947
Average Volume 64,789

Financial Ratios

Leverage Ratio1.04
Current Ratio33.15
Price / Book0.52
Price / Tangible Book0.52

Financial Strength

Piotroski F-Score 3 / 9
Price to Intrinsic Value8.42
Shiller PE Ratio2.52
Short Ratio6.30
Short % of Float1.26

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.96% 10 / 100   
1 Month -10.65% 28 / 100   
2 Months -14.22% 27 / 100   
6 Months -23.11% 24 / 100   
1 Year -22.49% 29 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog